Dynavax Technologies | Attività

Assets Cambiamento Data
Adma Biologics USD 329.18M 19.81M 2023-12
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Dynavax Technologies USD 997.1M 24.16M 2023-12
Gilead Sciences USD 62.13B 248M 2023-12
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
TG Therapeutics USD 329.59M 1.48M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Dynavax Technologies Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.